Exemestane in Reducing Breast Density in Postmenopausal Women at Risk for Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: exemestane|DRUG: Placebo
Sponsor: NCIC Clinical Trials Group